Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study.

BACKGROUND Electric conversion of atrial fibrillation is the most widely used and effective treatment for sinus rhythm restoration. However, it has a limited success rate and a high recurrence rate. HYPOTHESIS Pretreatment with calcium channel blocker may improve the efficacy by reversing the so-called "electric remodeling" phenomenon, also related to overload in cytosolic calcium. METHODS The efficacy of diltiazem or amiodarone pretreatment (oral, 1 month before and 1 month after conversion) on direct-current conversion of persistent atrial fibrillation was assessed in 120 patients, randomly assigned to 3 matched groups: A (n = 44, diltiazem); B (n = 46, amiodarone), and C (n = 30, digoxin). RESULTS Before electric conversion, all treatments significantly decreased mean heart rate. Spontaneous conversion to sinus rhythm was achieved in 6% of patients of group A (3 of 46) versus 25% of group B (11 of 44) and 3% (1 of 30) of group C (A/C vs B, P < .005). Current conversion was more successful in group B (91%) compared with group A (76%) and group C (67%) (B vs A/C, P < .05), with no difference in the electric threshold for effective conversion (P = not significant). At the 24-hour time point, early relapse of atrial fibrillation was similar between groups A and B (A, 2%; B, 3%; P = not significant) and lower than group C (12%) (P < .01), whereas at the 1-month time point the recurrence rate was lower in group B (28%) versus groups A (56%) and C (78%) (B vs A/C, P < .01). No significant side effects were reported. CONCLUSIONS Although diltiazem seems to be as effective as amiodarone in reducing early atrial fibrillation recurrences, diltiazem is less effective in determining spontaneous or electric conversion, with a higher recurrence rate at 2 months. Diltiazem pretreatment could be considered as only a second choice treatment in those patients in whom amiodarone is contraindicated.

[1]  M. Gasparini,et al.  Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. , 1999, Journal of the American College of Cardiology.

[2]  Bramahn . Singh,et al.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.

[3]  W. Lederer,et al.  Ca2+ flux through promiscuous cardiac Na+ channels: slip-mode conductance. , 1998, Science.

[4]  L. Jordaens,et al.  Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. , 1997, European heart journal.

[5]  M. Allessie,et al.  Verapamil reduces tachycardia-induced electrical remodeling of the atria. , 1997, Circulation.

[6]  A. Torbicki,et al.  Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct‐current cardioversion , 1997, Clinical cardiology.

[7]  D. Tweedie,et al.  The effects of changes to action potential duration on the calcium content of the sarcoplasmic reticulum in isolated guinea-pig ventricular myocytes , 1997, Pflügers Archiv.

[8]  M. Santini,et al.  Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. , 1996, Journal of the American College of Cardiology.

[9]  V. Fuster,et al.  Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. , 1996, Circulation.

[10]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[11]  W. Parmley,et al.  Acute amiodarone terminates ventricular fibrillation by modifying cellular Ca++ homeostasis in isolated perfused rat hearts. , 1995, The Journal of pharmacology and experimental therapeutics.

[12]  W. Barry,et al.  Intracellular Calcium Homeostasis in Cardiac Myocytes , 1993, Circulation.

[13]  R. Kronmal,et al.  Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. , 1992, Journal of the American College of Cardiology.

[14]  H. Crijns,et al.  Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. , 1992, JAMA.

[15]  J. Soler‐Soler,et al.  Electrical cardioversion after amiodarone administration. , 1992, American heart journal.

[16]  I. V. Van Gelder,et al.  Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. , 1991, The American journal of cardiology.

[17]  H. Crijns,et al.  Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. , 1991, The American journal of cardiology.

[18]  C. Kerr,et al.  Atrial flutter in patients treated for atrial fibrillation with propafenone. , 1990, The American journal of cardiology.

[19]  D H Singer,et al.  Amiodarone blocks calcium current in single guinea pig ventricular myocytes. , 1989, The Journal of pharmacology and experimental therapeutics.

[20]  R. Falk.  Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. , 1989, Annals of internal medicine.

[21]  D. Singer,et al.  Amiodarone-induced block of sodium current in isolated cardiac cells. , 1987, The Journal of pharmacology and experimental therapeutics.

[22]  L. Horowitz,et al.  Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. , 1985, Journal of the American College of Cardiology.

[23]  T. Graboys,et al.  Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. , 1983, American heart journal.

[24]  A. Goldberger,et al.  Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success. , 1982, American heart journal.

[25]  B. Lown.  Electrical reversion of cardiac arrhythmias. , 1967, British heart journal.

[26]  B. Lown,et al.  "Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients. , 1963, The New England journal of medicine.

[27]  A. Capucci,et al.  Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. , 2000, European heart journal.

[28]  J Haaksma,et al.  Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? , 1998, Journal of the American College of Cardiology.

[29]  H. Crijns,et al.  Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. , 1996, Archives of internal medicine.

[30]  J. Alpert,et al.  Amiodarone for refractory atrial fibrillation. , 1986, The American journal of cardiology.

[31]  G A Ewy,et al.  Response of atrial fibrillation to therapy: role of etiology and left atrial diameter. , 1980, Journal of electrocardiology.

[32]  UvA-DARE (Digital Academic Repository) Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone , 2022 .